Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to $282000.0.

  • CollPlant Biotechnologies' Share-based Compensation fell 4524.27% to $282000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 2248.52%. This contributed to the annual value of $1.7 million for FY2024, which is 1125.45% down from last year.
  • As of Q3 2025, CollPlant Biotechnologies' Share-based Compensation stood at $282000.0, which was down 4524.27% from $353000.0 recorded in Q2 2025.
  • CollPlant Biotechnologies' Share-based Compensation's 5-year high stood at $680000.0 during Q3 2022, with a 5-year trough of $275000.0 in Q4 2021.
  • Over the past 5 years, CollPlant Biotechnologies' median Share-based Compensation value was $461000.0 (recorded in 2022), while the average stood at $444421.1.
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 4575.94% in 2021, then surged by 8478.26% in 2022.
  • Over the past 5 years, CollPlant Biotechnologies' Share-based Compensation (Quarter) stood at $275000.0 in 2021, then soared by 59.64% to $439000.0 in 2022, then rose by 28.47% to $564000.0 in 2023, then fell by 24.82% to $424000.0 in 2024, then tumbled by 33.49% to $282000.0 in 2025.
  • Its Share-based Compensation stands at $282000.0 for Q3 2025, versus $353000.0 for Q2 2025 and $382000.0 for Q1 2025.